SBRT in oligometastatic/oligorecurrent NSCLC cancer patients: a new therapeutic approach

被引：0
|
作者：
Bracci, S. [1 ]
Agolli, L. [1 ]
Nicosia, L. [1 ]
Falco, T. [1 ]
Valeriani, M. [1 ]
Minniti, G. [1 ]
De Sanctis, V. [1 ]
Osti, M. F. [1 ]
Enrici, R. Maurizi [1 ]
机构：
[1] Univ Rome Sapienza, Radiat Oncol, Rome, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1181
引用
收藏
页码：S641 / S642
页数：2
相关论文
共 50 条
  • [31] Quality of life in oligometastatic prostate cancer patients treated with SBRT using EORTC questionnaires
    Li, Minglun
    Christian, Trapp
    Paul, Rogowski
    Nina, Schmidt-Hegemann
    Claus, Belka
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S151 - S152
  • [32] SBRT in patients with HCC/CCC or oligometastatic liver disease
    Gerum, S.
    Heinz, C.
    Belka, C.
    Ganswindt, U.
    Niyazi, M.
    Roeder, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 10 - 10
  • [33] Quality of life in oligometastatic prostate cancer patients treated with SBRT using EORTC form
    Ma, J.
    Rogowski, P.
    Trapp, C.
    Schmidt-Hegemann, N.
    Belka, C.
    Li, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1222 - S1223
  • [34] SBRT in patients with HCC/CCC or oligometastatic liver disease
    Gerum, S.
    Heinz, C.
    Belka, C.
    Niyazi, M.
    Ganswindt, U.
    Roeder, F.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S667 - S668
  • [35] The role of SBRT in oligorecurrent and oligoprogressive prostate cancer: a multi-institutional study
    Triggiani, L.
    Magrini, S.
    Bruni, A.
    Alongi, F.
    Magli, A.
    Bonetta, A.
    Livi, L.
    Santoni, R.
    Borghetti, P.
    Maddalo, M.
    Rolando, M. D.
    Ingrosso, G.
    Pasinetti, N.
    Buglione, M.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S276 - S276
  • [36] EVALUATION OF THE EFFECT OF ORGAN MOTION ON DOSE IN SBRT TREATMENTS FOR OLIGORECURRENT PROSTATE CANCER
    La Fauci, Francesco
    Marvaso, Giulia
    Augugliaro, Matteo
    Mazzola, Giovanni Carlo
    Comi, Stefania
    Pepa, Matteo
    Zaffaroni, Mattia
    Corrao, Giulia
    Mistretta, Francesco Alessandro
    Gandini, Sara
    Petralia, Giuseppe
    Cattani, Federica
    De Cobelli, Ottavio
    Orecchia, Roberto
    Jereczek-Fossa, Barbara Alicja
    ANTICANCER RESEARCH, 2021, 41 (10) : 5279 - 5281
  • [37] Evaluation of organ motion effect on dose in SBRT treatments for oligorecurrent prostate cancer
    La Fauci, F.
    Marvaso, G.
    Augugliaro, M.
    Comi, S.
    Pepa, M.
    Zaffaroni, M.
    Corrao, G.
    Mistretta, F. A.
    Gandini, S.
    Petralia, G.
    Cattani, F.
    De Cobelli, O.
    Orecchia, R.
    Jereczek-Fossa, B. A.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1284 - S1285
  • [38] SBRT in oligometastatic uterine cancer: a large, multicenter, retrospective study
    Macchia, G.
    Pezzulla, D.
    Campitelli, M.
    Laliscia, C.
    Fodor, A.
    Bonome, P.
    Draghini, L.
    Ippolito, E.
    De Sanctis, V.
    Ferioli, M.
    Titone, F.
    Balcet, V.
    Di Cataldo, V.
    Russo, D.
    Vicenzi, L.
    Cossa, S.
    Lucci, S.
    Deodato, F.
    Gambacorta, M. A.
    Ferrandina, G.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S18 - S19
  • [39] Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer
    Gkika, E.
    Adebahr, S.
    Kirste, S.
    Schimek-Jasch, T.
    Wiehle, R.
    Claus, R.
    Wittel, U.
    Nestle, U.
    Baltas, D.
    Grosu, A. L.
    Brunner, T. B.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (06) : 433 - 443
  • [40] SBRT for Oligometastatic Non-Small Cell Lung Cancer
    Herman, M. P.
    Dagan, R.
    Yeung, A. R.
    Bryant, C.
    Morris, C. G.
    Okunieff, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S609 - S610
12345